Kyle R. Rizzo, Cynthia Jean Yen, Joshua Quint, Cora Hoover, Robert Schechter
{"title":"Sociodemographic disparities in COVID-19 and RSV vaccine uptake among California adults ≥60 years old who received influenza vaccination","authors":"Kyle R. Rizzo, Cynthia Jean Yen, Joshua Quint, Cora Hoover, Robert Schechter","doi":"10.1016/j.vaccine.2025.127535","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>In 2023, adults ≥60 years old were eligible to receive updated influenza and COVID-19 vaccines along with newly available respiratory syncytial virus (RSV) vaccines. Vaccine acceptance for influenza is typically high among this age cohort. We assessed COVID-19 and RSV vaccine uptake among influenza vaccine recipients to identify sociodemographic disparities among California adults ≥60 years old who did not receive all three vaccinations.</div></div><div><h3>Methods</h3><div>We used a cross-sectional design to assess the prevalence of COVID-19 and RSV vaccination among California adults ≥60 years old with an influenza vaccination reported to the California Immunization Registry during 08/01/2023–06/30/2024. We used log binomial regression to calculate prevalence ratios (PR) and 95 % confidence intervals (95 %CI) that measured associations between recipient sociodemographic characteristics and receipt of all three vaccines.</div></div><div><h3>Results</h3><div>Among 4,471,042 adults included in this study, 901,815 (20 %) received all three vaccinations during 2023–2024. The prevalence for receiving COVID-19 and RSV vaccines among Latino adults residing in the lowest resource communities was 80 % less (PR: 0.20, 95 %CI: 0.19, 0.20) than among white adults residing in the highest resource communities when the vaccination status of the comparison group was limited to influenza only vaccine recipients.</div></div><div><h3>Conclusions</h3><div>We identified concerning disparities in the uptake of COVID-19 and RSV vaccines among older adults during the 2023–2024 respiratory virus season in California. Provider awareness of these disparities may help improve vaccine uptake among older adult populations when patients seek their seasonal influenza vaccinations.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"62 ","pages":"Article 127535"},"PeriodicalIF":4.5000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X25008321","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
In 2023, adults ≥60 years old were eligible to receive updated influenza and COVID-19 vaccines along with newly available respiratory syncytial virus (RSV) vaccines. Vaccine acceptance for influenza is typically high among this age cohort. We assessed COVID-19 and RSV vaccine uptake among influenza vaccine recipients to identify sociodemographic disparities among California adults ≥60 years old who did not receive all three vaccinations.
Methods
We used a cross-sectional design to assess the prevalence of COVID-19 and RSV vaccination among California adults ≥60 years old with an influenza vaccination reported to the California Immunization Registry during 08/01/2023–06/30/2024. We used log binomial regression to calculate prevalence ratios (PR) and 95 % confidence intervals (95 %CI) that measured associations between recipient sociodemographic characteristics and receipt of all three vaccines.
Results
Among 4,471,042 adults included in this study, 901,815 (20 %) received all three vaccinations during 2023–2024. The prevalence for receiving COVID-19 and RSV vaccines among Latino adults residing in the lowest resource communities was 80 % less (PR: 0.20, 95 %CI: 0.19, 0.20) than among white adults residing in the highest resource communities when the vaccination status of the comparison group was limited to influenza only vaccine recipients.
Conclusions
We identified concerning disparities in the uptake of COVID-19 and RSV vaccines among older adults during the 2023–2024 respiratory virus season in California. Provider awareness of these disparities may help improve vaccine uptake among older adult populations when patients seek their seasonal influenza vaccinations.
期刊介绍:
Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.